<DOC>
	<DOC>NCT02241096</DOC>
	<brief_summary>To determine safe concentration level of lidocaine infusion in children.</brief_summary>
	<brief_title>PK Intravenous Lidocaine Infusion</brief_title>
	<detailed_description>This study will address the working hypothesis that intravenous lidocaine may be administered as a bolus followed by an infusion with reliable and safe blood levels of lidocaine. Serial blood draws will be obtained to determine safety of lidocaine doses used in this study by measuring blood levels of lidocaine and its metabolites.</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>male or female children 315 years of age ASA physical status 13 scheduled for colorectal surgery with abdominal incision ASA physical status &gt; 3 postoperative intubation planned ahead of surgery history of chronic use of opioid (use longer than 3 months) history of hepatic, renal, or cardiac failure history of significant liver disease including liver failure, acute or chronic hepatitis, hepatomegaly, portal hypertension and elevated liver enzymes history of organ transplant BMI &gt; 30 history of cardiac arrhythmia history of long QT syndrome history of allergic reaction to lidocaine or similar agents history of seizure disorder patient without PICC or other central access with contraindication to inhalation induction family history or known patient susceptibility to malignant hyperthermia</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>